July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
miR15a Regulates NLRP3 Inflammasome Actions in the Retinal Vasculature
Author Affiliations & Notes
  • Elizabeth Curtiss
    Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, Michigan, United States
  • Li Liu
    Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, Michigan, United States
  • Youde Jiang
    Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, Michigan, United States
  • Jena J Steinle
    Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, Michigan, United States
    Ophthalmology, Wayne State University School of Medicine, Detroit, Michigan, United States
  • Footnotes
    Commercial Relationships   Elizabeth Curtiss, None; Li Liu, None; Youde Jiang, None; Jena Steinle, None
  • Footnotes
    Support  R01EY022330, P30EY04068 (PI:Hazlett), and Unrestricted Grant to the Department of Ophthalmology from Research to Prevent Blindness (Kresge Eye Institute)
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 3547. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Elizabeth Curtiss, Li Liu, Youde Jiang, Jena J Steinle; miR15a Regulates NLRP3 Inflammasome Actions in the Retinal Vasculature. Invest. Ophthalmol. Vis. Sci. 2018;59(9):3547.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate whether miR15a regulates NLR family pyrin domain containing 3 (NLRP3) inflammasome actions in mice retinal vasculature and human retinal endothelial cells (REC).

Methods : Whole retinal lysates from both miR15a overexpressing mice and endothelial cell specific miR15a knockout mice were used to investigate protein levels of Forkhead box protein O1 (Foxo1), NLRP3, interleukin 1 beta (IL-1ß), and cleaved caspase 1. Primary human REC were cultured in normal and high glucose followed by transfection with a miR15a mimic or a recombinant human Foxo1 (rhFoxo1) agonist for protein analyses of Foxo1, NLRP3, IL-1ß, and cleaved caspase 1. miR15a expression was verified by quantitative PCR. A luciferase binding assay was used to examine whether miR15a directly binds Foxo1.

Results : miR15a directly binds to Foxo1. In mouse retinal lysates, loss of miR15a led to an increase in Foxo1, NLRP3, IL-1ß levels, as well as cleavage of caspase 1. REC grown in high glucose transfected with the miR15a mimic had decreased levels of Foxo1, NLRP3, IL-1ß, and cleaved caspase 1. Treatment with rhFoxo1 of REC cultured in high glucose had increased levels of NLRP3, IL-1ß, and cleaved caspase 1.

Conclusions : miR15a regulates NLRP3 actions in the retinal vasculature. Work in mice showed that loss of miR15a increased NLRP3 pathway signaling. miR15a mimics decreased levels of NLRP3, Foxo1, IL-1ß, and cleaved caspase 1 in REC grown in high glucose. Taken together, miR15a may reduce inflammasome actions in the retinal vasculature through reductions in Foxo1.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×